000 02622cam a2200349 a 4500
003 EG-GiCUC
005 20250223032328.0
008 190716s2019 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.08.05.Ph.D.2019.Gh.D
100 0 _aGhada Hamdy Mahmoud Barakat
245 1 0 _aDetermination of some drugs and prodrugs in combination with their degradation productsor active metabolites /
_cGhada Hamdy Mahmoud Barakat ; Supervised Sonia Talaat Hassib , Elham Anwer Taha , Ehab Farouk Elkady
246 1 5 _aتقدير بعض الأدويه و طلائع الأدويه بالتواجد مع نواتج تكسيرها أونواتج الأيض النشطه
260 _aCairo :
_bGhada Hamdy Mahmoud Barakat ,
_c2019
300 _a243 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutical Chemistry
520 _aThe study in this thesis included new analytical methods for the determination of some drugs and prodrugs in combination with their degradation products or active metabolites.Drugs cited in the thesis aresome antiviral drugs, antidiabeticdrugs and drugs used for treatment of inflammatory bowel disease. These methods include RP-LC method for simultaneous determination of seven antiviral drugs, the quantification was achieved at 254 nm for (acyclovir, ganciclovir, penciclovir and valaciclovir hydrochloride) and at 220 nm for (lamivudine, oseltamivir phosphate and ribavirin). Moreover, bioanalytical method for simultaneous determination of lamivudine and penciclovir in spiked human plasma wasdeveloped using valaciclovirHCl as internal standard. Validation of bioanalyticalmethod was performed according to European Medicines Agency guidelines.RP-LC method for determination of daclatasvirdihydrochloridewas developed and the study of its degradation behavior was investigated.Peak purity was checked for principle drug and its alkaline induced degradation product and the pathway of alkaline hydrolysis of daclatasvirdihydrochloride was suggested by LC/MS
530 _aIssued also as CD
653 4 _aAntidiabetic drugs
653 4 _aAntiviral drugs
653 4 _aDrugs used for treatment of inflammatory bowel disease
700 0 _aEhab Farouk Elkady ,
_eSupervisor
700 0 _aElham Anwer Taha ,
_eSupervisor
700 0 _aSonia Talaat Hassib ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aNazla
_eRevisor
905 _aShimaa
_eCataloger
942 _2ddc
_cTH
999 _c72868
_d72868